A detailed history of Principal Securities, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Principal Securities, Inc. holds 15,189 shares of LLY stock, worth $11.7 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
15,189
Previous 14,162 7.25%
Holding current value
$11.7 Million
Previous $12.8 Billion 4.95%
% of portfolio
0.33%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $792,987 - $985,940
1,027 Added 7.25%
15,189 $13.5 Billion
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $1.92 Million - $2.41 Million
2,651 Added 23.03%
14,162 $12.8 Billion
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $1.67 Million - $2.24 Million
2,823 Added 32.49%
11,511 $8.96 Billion
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $4.56 Million - $5.38 Million
8,688 New
8,688 $5.06 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.